Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-interventional Study on Uncontrolled Hypertensive Patients for Evaluating Efficacy of Candesartan Cilexetil as Monotherapy or add-on Therapy.

NCT00573742 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00573742
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00573742 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-interventional Study on Uncontrolled Hypertensive Patients for Evaluating Efficacy of Candesartan Cilexetil as Monotherapy or add-on Therapy.
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
September 30, 2007
Completion date
February 29, 2008
Enrollment
1,940 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

primary hypertension